Formulary Committee members with a potential conflict of interest permitted to participate in committee communications and discussions, commissioner of human services required to develop a public comment process for recommendations, and committee required to seek expertise from the Minnesota Rare Disease Advisory Council.
Sponsored By: Liz Reyer (Democratic)
Introduced
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & Cosponsors
Sponsor
Liz Reyer
Democratic • House
Cosponsors
Robert Bierman
Democratic • House
Roll Call Votes
No roll call votes available for this bill.
Actions Timeline
Introduction and first reading, referred to Health Finance and Policy
4/7/2026House
Bill Text
As Introduced
Related Bills
HF 5099 — Rosemount; new water treatment facility funding provided, bonds issued, and money appropriated.
SF 5249 — Constitutional amendment proposal to allow the lieutenant governor to cast a vote in the house of representatives in case of a tie
HF 5077 — Reduction to local government aid to a county or city that uses the incorrect state flag established.
SF 5250 — Metropolitan Mosquito Control District public health infrastructure appropriation and bond issuance authorization
HF 5102 — Motor vehicle registration tax modified.
SF 5248 — Elections provisions modification